日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recent advances in hydrogel-based therapeutics for lung cancer

近年来,基于水凝胶的肺癌治疗方法取得了显著进展。

Sun, Ke; Qiu, Jiaoyan; Wang, Yawen; Han, Fengyi; Song, Huaxin; Wu, Tong; Wang, Yuanfei; Jiao, Wenjie

Development and validation of a serum inflammatory biomarker-driven machine-learning model for prognostic stratification in surgical limited-stage small cell lung cancer

开发和验证基于血清炎症生物标志物的机器学习模型,用于手术切除的局限期小细胞肺癌的预后分层

Yao, Zhiyuan; Li, Changlei; Han, Fengyi; Qin, Yi; Sun, Xiao; Wang, Guohua; Yu, Enzheng; Song, Peng; Liu, Hanqun; Jiao, Wenjie

Use of consensus clustering to identify subtypes of clinical early-stage non-small cell lung cancer and its association with lymph node metastasis

利用共识聚类法识别临床早期非小细胞肺癌亚型及其与淋巴结转移的关系

Qin, Yi; Wo, Yang; Han, Fengyi; Zhao, Yandong; Wang, Yawei

Role of CENPL, DARS2, and PAICS in determining the prognosis of patients with lung adenocarcinoma.

CENPL、DARS2 和 PAICS 在确定肺腺癌患者预后中的作用

Xu Rongjian, Han Fengyi, Zhao Yandong, Liu Ao, An Ning, Wang Baogang, Zardo Patrick, Sanz-Santos José, Franssen Aimée J P M, de Loos Erik R, Zhao Min

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway

miR-223通过IGF1R/PI3K/Akt信号通路逆转EGFR-TKI的耐药性

Jing Han, Fengyi Zhao, Jing Zhang, Haizhen Zhu, Hu Ma, Xuetao Li, Lina Peng, Jianguo Sun, Zhengtang Chen